We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nanoparticle-Augmented Spectroscopy Reveals Structure of Alzheimer's Disease Peptide

By LabMedica International staff writers
Posted on 06 Sep 2015
The use of lipid bilayer-encapsulated silver nanoparticles to increase the sensitivity of a Raman spectroscopy technique allowed researchers to determine the structure of Alzheimer's disease-related membrane-attached oligomers of amyloid-beta40 (Abeta40) peptide.

Raman spectroscopy exploits the inelastic scattering (so-called “Raman” scattering) phenomena to detect spectral signatures of important disease progression biomarkers, including lipids, proteins, and amino acids. More...
In a novel modification of the Raman technique, investigators at the Tata Institute of Fundamental Research (Mumbai, India) and the University of Toronto (Canada) introduced a surface enhanced Raman spectroscopy technique that could determine the conformation of membrane-bound proteins, at low micromolar concentrations, and also in the presence of a substantial membrane-free fraction. Unlike conventional surface enhanced Raman spectroscopy, this approach did not require immobilization of molecules, as it used spontaneous binding of proteins to lipid bilayer-encapsulated silver nanoparticles.

The investigators applied this technique to probe the structure of membrane-attached oligomers of amyloid-beta40 (Abeta40), whose conformation is needed to explain certain aspects of Alzheimer’s disease.

They reported in the August 25, 2015, online edition of the journal ACS Nano that isotope-shifts in the Raman spectra helped them to obtain secondary structure information at the level of individual residues. Results showed the presence of a beta-turn, flanked by two beta-sheet regions. The investigators then used solid-state NMR data to confirm the presence of the beta-sheets in these regions. In the membrane-attached oligomer, they found a strongly contrasting and near-orthogonal orientation of the backbone H-bonds compared to what is found in the mature, less-toxic Abeta fibrils.

Contributing author Dr. Gilbert Walker, professor of chemistry at the University of Toronto, said, "While the amyloid beta got fooled by the fat layer-encased silver nanoparticles that mimicked the outer membranes of living cells and stuck to the membrane, the silver inside enhanced the signal to a measurable level and acted as a light beacon to reveal the peptide signature."

"Everybody wants to make the key to solve Alzheimer's disease, but we do not know what the lock looks like. We now have a glimpse of something which could be the lock. May be it is still not the real thing, but as of now, this is our best bet," said senior author Dr. Sudipta Maiti, professor of chemical sciences at the Tata Institute of Fundamental Research.

Related Links:

Tata Institute of Fundamental Research
University of Toronto



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.